Regulatory Webinars
-
Managing A Continually Evolving Disclosure Landscape
2/20/2024
Compliance is more important than ever. Keep up with how regions are enforcing disclosure requirements by learning how to adjust compliance strategies accordingly.
-
Exploring The Interactions Between Validation, Technology Transfer
1/24/2024
Listen as Gerardo Gomez delves into the intricate relationship between validation and technology transfer, taking into account the perspectives and standards set by regulators.
-
Navigating The Unique Attributes Of Psychedelic Drug Development
1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.
-
ICH E6(R3): Practical Steps For Implementation
12/14/2023
Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.
-
Early Access Programs: What They Are And How To Plan For Them
12/5/2023
Explore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
-
EU CTR: An Introduction To European Clinical Trial Transparency
12/4/2023
Listen in as regulatory expert Pierre-Frederic Omnes takes viewers through an overview of the European Clinical Trial Regulation (EU CTR) and its impact on clinical trials.
-
Navigating The Process Of Technology Transfer
11/14/2023
Olena Chervonenko, Associate Director Quality Management and Compliance at PharmaLex, provides deeper insights into technology transfer and essential factors for achieving success.
-
Meeting Diversity Goals Through Smart Trial Design Strategies
11/8/2023
Delve into strategies for effectively monitoring and reporting progress toward achieving patient diversity objectives.
-
An Overview Of Health Canada's CTA Process
10/24/2023
Experience expedited timelines by conducting trials in Canada. Our expertise in navigating Health Canada's CTA process ensures smooth and efficient approvals.
-
The Advantages Of Conducting Early Phase Trials In North America
10/24/2023
In this webinar, Altasciences discuss the similarities and differences of conducting early phase research in North America versus other geographic regions.